{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:33Z","timestamp":1792783413466,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework EU Program","doi-asserted-by":"publisher","award":["667224"],"award-info":[{"award-number":["667224"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iPREDICT project","award":["G0D0520N"],"award-info":[{"award-number":["G0D0520N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40262-022-01164-9","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T01:02:33Z","timestamp":1661821353000},"page":"1545-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates"],"prefix":"10.1007","volume":"61","author":[{"given":"Wan-Yu","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P. C.","family":"Dorlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin D. R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ALBINO Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel R.","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nijstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Annink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Maiwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna el","family":"Bakkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam M.","family":"van Weisenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Poets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Benders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"van Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Naulaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Bassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Klebermass-Schrehof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximo","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hercilia","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Stiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo","family":"Mets\u00e4ranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampsa","family":"Vanhatalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Mazela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Metsvaht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselinda","family":"van der Vlugt-Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"1164_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/j.nainr.2011.07.004","volume":"11","author":"KA Allen","year":"2011","unstructured":"Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn Infant Nurs Rev. 2011;11:125\u201333.","journal-title":"Newborn Infant Nurs Rev"},{"key":"1164_CR2","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez RT, Puig JG. Purine metabolism in the pathogenesis of hyperuricemia and inborn errors of purine metabolism associated with disease. In:\u00a0Robert Terkeltaub, Gout and other crystal arthropathies. W.B. Saunders\u00a0Philadelphia; 2012. pp. 36\u201350. https:\/\/doi.org\/10.1016\/B978-1-4377-2864-4.10003-X, https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978143772864410003X","DOI":"10.1016\/B978-1-4377-2864-4.10003-X"},{"key":"1164_CR3","doi-asserted-by":"crossref","unstructured":"Wheaton WW, Chandel NS. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol. 2011;300:C385\u201393.","DOI":"10.1152\/ajpcell.00485.2010"},{"key":"1164_CR4","doi-asserted-by":"crossref","unstructured":"Ichida K, Hosoyamada M, Hosoya T, Endou H. Primary metabolic and renal hyperuricemia. Genet Dis Kidney.\u00a0Academic Press, Richard P. Lifton and Stefan Somlo and Gerhard H. Giebisch and Donald W. Seldin,\u00a0Kimiyoshi Ichida and Makoto Hosoyamada and Tatsuo Hosoya and Hitoshi Endou, San Diego\u00a02009;651\u201360.\u00a0978-0 12-449851-8, https:\/\/doi.org\/10.1016\/B978-0-12-449851-8.00038-3, https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780124498518000383.","DOI":"10.1016\/B978-0-12-449851-8.00038-3"},{"key":"1164_CR5","doi-asserted-by":"crossref","unstructured":"Murray AW. The biological significance of purine salvage. Annu Rev Biochem. 1971;40:811\u201326. https:\/\/doi.org\/10.1146\/annurev.bi.40.070171.004115","DOI":"10.1146\/annurev.bi.40.070171.004115"},{"key":"1164_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1203\/00006450-198802000-00001","volume":"23","author":"OD Saugstad","year":"1988","unstructured":"Saugstad OD. Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res. 1988;23:143\u201350.","journal-title":"Pediatr Res"},{"key":"1164_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41390-018-0176-8","volume":"85","author":"OD Saugstad","year":"2019","unstructured":"Saugstad OD, Oei JL, Lakshminrusimha S, Vento M. Oxygen therapy of the newborn from molecular understanding to clinical practice. Pediatr Res. 2019;85:20\u20139.","journal-title":"Pediatr Res"},{"key":"1164_CR8","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","volume":"388","author":"L Liu","year":"2016","unstructured":"Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388:3027\u201335.","journal-title":"Lancet"},{"key":"1164_CR9","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.2174\/1381612823666170918123307","volume":"23","author":"KV Annink","year":"2018","unstructured":"Annink KV, Franz AR, Derks JB, R\u00fcdiger M, van Bel F, Benders MJNL. Allopurinol: old drug, new indication in neonates? Curr Pharm Des. 2018;23:5935\u201342.","journal-title":"Curr Pharm Des"},{"key":"1164_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12887-019-1566-8","volume":"19","author":"CA Maiwald","year":"2019","unstructured":"Maiwald CA, Annink KV, R\u00fcdiger M, Benders MJNL, Van Bel F, Allegaert K, et al. Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority phase. BMC Pediatr. 2019;19:210.","journal-title":"BMC Pediatr"},{"key":"1164_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00003088-200746080-00001","volume":"46","author":"RO Day","year":"2007","unstructured":"Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokinet. 2007;46:623\u201344.","journal-title":"Clin Pharmacokinet"},{"key":"1164_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1203\/00006450-197504000-00002","volume":"9","author":"OD Saugstad","year":"1975","unstructured":"Saugstad OD. Hypoxanthine as a measurement of hypoxia. Pediatr Res. 1975;9:158\u201361.","journal-title":"Pediatr Res"},{"key":"1164_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1651-2227.2007.00361.x","volume":"96","author":"A R\u00f3ka","year":"2007","unstructured":"R\u00f3ka A, V\u00e1s\u00e1rhelyi B, Bodrogi E, Machay T, Szab\u00f3 M. Changes in laboratory parameters indicating cell necrosis and organ dysfunction in asphyxiated neonates on moderate systemic hypothermia. Acta Paediatr. 2007;96:1118\u201321.","journal-title":"Acta Paediatr"},{"key":"1164_CR14","first-page":"62","volume":"56","author":"S Beken","year":"2014","unstructured":"Beken S, Ayd\u0131n B, Dilli D, Erol S, Zenciro\u011flu A, Okumu\u015f N. Can biochemical markers predict the severity of hypoxic-ischemic encephalopathy? Turk J Pediatr. 2014;56:62\u20138.","journal-title":"Turk J Pediatr"},{"key":"1164_CR15","doi-asserted-by":"crossref","unstructured":"Patel KP. Urinary uric acid\/creatinine ratio: a marker for perinatal asphyxia. J Clin Diagnos Res. 2017;11:SC08\u201310.","DOI":"10.7860\/JCDR\/2017\/22697.9267"},{"key":"1164_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40262-021-01068-0","volume":"61","author":"W-Y Chu","year":"2022","unstructured":"Chu W-Y, Annink KV, Nijstad AL, Maiwald CA, Schroth M, El Bakkali L, et al. Pharmacokinetic\/pharmacodynamic modelling of allopurinol, its active metabolite oxypurinol, and biomarkers hypoxanthine, xanthine and uric acid in hypoxic-ischemic encephalopathy neonates. Clin Pharmacokinet. 2022;61:321\u201333.","journal-title":"Clin Pharmacokinet"},{"key":"1164_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s40262-021-00991-6","volume":"60","author":"N Deferm","year":"2021","unstructured":"Deferm N, Annink KV, Faelens R, Schroth M, Maiwald CA, el Bakkali L, et al. Glomerular filtration rate in asphyxiated neonates under therapeutic whole-body hypothermia, quantified by mannitol clearance. Clin Pharmacokinet. 2021;60:897\u2013906.","journal-title":"Clin Pharmacokinet"},{"key":"1164_CR18","unstructured":"Beal S, Sheiner L, Boeckmann A, Bauer R. NONMEM users guides. ICON Development Solutions, Gaithersburg, Marylan; 2013."},{"key":"1164_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","volume":"75","author":"L Lindbom","year":"2004","unstructured":"Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN): a Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75:85\u201394.","journal-title":"Comput Methods Programs Biomed"},{"key":"1164_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","volume":"101","author":"RJ Keizer","year":"2011","unstructured":"Keizer RJ, van Benten M, Beijnen JH, Schellens JHM, Huitema ADR. Pira\u00f1a and PCluster: a modeling environment and cluster infrastructure for NONMEM. Comput Methods Programs Biomed. 2011;101:72\u20139.","journal-title":"Comput Methods Programs Biomed"},{"key":"1164_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1651-2227.1997.tb08581.x","volume":"86","author":"CM Thompson","year":"1997","unstructured":"Thompson CM, Puterman AS, Linley LL, Hann FM, Van Der Elst CW, Molteno CD, et al. The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome. Acta Paediatr. 1997;86:757\u201361.","journal-title":"Acta Paediatr"},{"key":"1164_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4065\/81.9.1232","volume":"81","author":"EC Ebert","year":"2006","unstructured":"Ebert EC. Hypoxic liver injury. Mayo Clin Proc. 2006;81:1232\u20136.","journal-title":"Mayo Clin Proc"},{"key":"1164_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1651-2227.2010.01802.x","volume":"99","author":"M Karlsson","year":"2010","unstructured":"Karlsson M, Wiberg-Itzel E, Chakkarapani E, Blennow M, Winbladh B, Thoresen M. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 2010;99:1139\u201344.","journal-title":"Acta Paediatr"},{"key":"1164_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/NPM-1853","volume":"12","author":"A Sehgal","year":"2019","unstructured":"Sehgal A, Linduska N, Huynh C. Cardiac adaptation in asphyxiated infants treated with therapeutic hypothermia. J Neonatal Perinatal Med. 2019;12:117\u201325.","journal-title":"J Neonatal Perinatal Med."},{"key":"1164_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13:143.","journal-title":"AAPS J"},{"key":"1164_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10928-017-9542-0","volume":"44","author":"AG Dosne","year":"2017","unstructured":"Dosne AG, Bergstrand M, Karlsson MO. An automated sampling importance resampling procedure for estimating parameter uncertainty. J Pharmacokinet Pharmacodyn. 2017;44:509\u201320.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1164_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0026-0495(81)90142-6","volume":"30","author":"IH Fox","year":"1981","unstructured":"Fox IH. Metabolic basis for disorders of purine nucleotide degradation. Metabolism. 1981;30:616\u201334.","journal-title":"Metabolism"},{"key":"1164_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1471-4159.1987.tb03419.x","volume":"49","author":"H Hagberg","year":"1987","unstructured":"Hagberg H, Andersson P, Lacarewicz J, Jacobson I, Butcher S, Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem. 1987;49:227\u201331.","journal-title":"J Neurochem"},{"key":"1164_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cbpa.2015.10.021","volume":"191","author":"V-M del Castillo","year":"2016","unstructured":"del Castillo V-M, Hern\u00e1ndez-Camacho CJ, M\u00e9ndez-Rodr\u00edguez LC, Zenteno-Sav\u00edn T. Purine metabolism in response to hypoxic conditions associated with breath-hold diving and exercise in erythrocytes and plasma from bottlenose dolphins (Tursiops truncatus). Comp Biochem Physiol A Mol Integr Physiol. 2016;191:196\u2013201.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"11","key":"1164_CR30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2217\/bmm-2019-0049","volume":"13","author":"O Fisher","year":"2019","unstructured":"Fisher O, Benson RA, Imray CH. The clinical application of purine nucleosides as biomarkers of tissue ischemia and hypoxia in humans in vivo. Biomark Med. 2019;13(11):953\u201365.","journal-title":"Biomark Med"},{"key":"1164_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1203\/00006450-199704000-00010","volume":"41","author":"PJ Marro","year":"1997","unstructured":"Marro PJ, Baumgart S, Delivoria-Papadopoulos M, Zirin S, Corcoran L, McGaurn SP, et al. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res. 1997;41:513\u201320.","journal-title":"Pediatr Res"},{"key":"1164_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.brainres.2005.11.061","volume":"1073\u20131074","author":"PJ Marro","year":"2006","unstructured":"Marro PJ, Mishra OP, Delivoria-Papadopoulos M. Effect of allopurinol on brain adenosine levels during hypoxia in newborn piglets. Brain Res. 2006;1073\u20131074:444\u201350.","journal-title":"Brain Res"},{"key":"1164_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0306-4522(97)00172-3","volume":"81","author":"QS Si","year":"1997","unstructured":"Si QS, Nakamura Y, Kataoka K. Hypothermic suppression of microglial activation in culture: inhibition of cell proliferation and production of nitric oxide and superoxide. Neuroscience. 1997;81:223\u20139.","journal-title":"Neuroscience"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-022-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-022-01164-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-022-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T10:39:21Z","timestamp":1668249561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-022-01164-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s40262-022-01164-9","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"24 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ALBINO study is funded under the Horizon 2020 Framework EU Program call H2020-PHC-2015-two-stage grant 667224. The research on the pharmacokinetics during whole body hypothermia (KA) is further supported by the iPREDICT project (FWO Senior research project, fundamental research, G0D0520N).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data used in this study were acquired in accordance with the Declaration of Helsinki and the guidelines of Good Clinical Practice. The ALBINO study was granted by institutional review boards and independent ethics committees. The Medical Ethics Committee of the University Medical Centre Utrecht and the Central Committee on Human Research approved the study including the specific pharmacokinetic sub-study for the Netherlands (NL57237.041.16). The German Federal Authority (EudraCT 2016-000222-19) as well as the leading Ethics Committee of T\u00fcbingen approved the study for Germany.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Short oral consent was obtained from at least one parent before administering the study medication. After the first dose, but before the (potential) second dose, full written parental consent was obtained. In the case where parents did not sign the informed consent, blood samples already collected shortly after birth were destroyed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The raw data are available upon reasonable request by an e-mail to the corresponding author, while blinding for group allocation should be respected until the primary outcome analysis has been finalized.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KA and the ALBINO study group were responsible for protocol development, study conduct, study registration, study recruitment, and data collection. Population pharmacokinetic-pharmacodynamic modeling was performed by WC, TD, and AH. The draft of the manuscript was written and reviewed by WC, KA, TD, and AH. All authors and contributors have read and commented on the manuscript and have approved the submitted version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}